1. Expression and prognostic analyses of early growth response proteins (EGRs) in human breast carcinoma based on database analysis
   Yuchang Fei et al, 2019, PeerJ CrossRef
2. Prognostic Factors in Operable Breast Cancer Treated with Neoadjuvant Chemotherapy: Towards a Quantification of Residual Disease
   Sarah Mombelli et al, 2015, Oncology CrossRef
3. Knockdown of Oligosaccharyltransferase Subunit Ribophorin 1 Induces Endoplasmic-Reticulum-Stress-Dependent Cell Apoptosis in Breast Cancer
   Jiajun Ding et al, 2021, Frontiers in Oncology CrossRef
4. Measurement of Residual Disease After Neoadjuvant Chemotherapy
   Catherine Abrial et al, 2008, Journal of Clinical Oncology CrossRef
5. Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts
   Nina Oparina et al, 2021, Cancers CrossRef
6. Correlation Between Numeric Gadolinium-Enhanced Dynamic MRI Ratios and Prognostic Factors and Histologic Type of Breast Carcinoma
   Hiroyuki Narisada et al, 2006, American Journal of Roentgenology CrossRef
7. Agreement between core needle biopsy and surgical excision product: the importance of the invasive breast carcinoma grading system
   Rodrigo Justi Nogueira et al, 2022, Virchows Archiv CrossRef
8. Enhancing Clinical Support for Breast Cancer with Deep Learning Models Using Synthetic Correlated Diffusion Imaging
   Chi-en Amy Tai et al, 2024, Applications of Medical Artificial Intelligence CrossRef
9. An Ideal Prognostic Test for Estrogen Receptor–Positive Breast Cancer?
   Soonmyung Paik et al, 2008, Journal of Clinical Oncology CrossRef
10. The Systemic Inflammation Response Index as an Independent Predictor of Survival in Breast Cancer Patients: A Retrospective Study
    Mengliu Zhu et al, 2022, Frontiers in Molecular Biosciences CrossRef
11. Hormone Receptor, Grade, Human Epidermal Growth Factor Receptor 2, and Topoisomerase II As Predictors of Response to Chemotherapy
    Rita S. Mehta, 2008, Journal of Clinical Oncology CrossRef
12. Somatic Mutations and Altered Expression of the Candidate Tumor Suppressors CSNK1ε , DLG1 , and EDD/hHYD in Mammary Ductal Carcinoma
    Tannin J. Fuja et al, 2004, Cancer Research CrossRef